首页> 外文期刊>Journal of renal nutrition: the official journal of the Council on Renal Nutrition of the National Kidney Foundation >A controlled trial of intermittent enteral nutrient supplementation in maintenance hemodialysis patients.
【24h】

A controlled trial of intermittent enteral nutrient supplementation in maintenance hemodialysis patients.

机译:饲养血液透析患者间歇性肠内营养补充的对照试验。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: This controlled trial was undertaken to evaluate the benefits of short-term enteral nutrient supplementation in maintenance hemodialysis (MHD) patients using a high-calorie and high-protein blend formula (low-cost home-prepared [HP] blend or a commercially available supplement) and to study its effect on selected parameters of nutritional status. The acceptability and palatability of the HP blend formula, ease of use, and cost were also assessed in comparison with the commercial nutritional supplement (CNS). DESIGN: Randomized controlled trial. SETTING: Hemodialysis (HD) unit of a tertiary referral care hospital in Southern India. PATIENTS: Nondiabetic adult MHD patients with no intercurrent illness, on regular thrice weekly MHD for at least 1 month before recruitment, with a body mass index (BMI) <20 and a serum albumin level of <4.0 g/dL. Patients were randomized into control group and experimental group, the latter in turn to recieve either CNS or HP blend. INTERVENTION: The control groupreceived appropriate monitoring, including dietary recall and counselling for the prescribed diet (protein intake of 1.2 g/kgIBW/d and energy of 35 to 45 kcal/kgIBW/d) but no specific post-HD supplement. Patients in the supplement group received the respective supplement post-HD (providing 500 kcal and 15 g protein) for 1 month in addition to the monitored diet prescription. Main Outcome Measures: (1) Nutritional status parameters, BMI and serum albumin; (2) functional status on a 10-point Karnofsky scale; (3) adverse metabolic effects, hyperphosphatemia at start and end of study; and (4) subjective scoring for appetite, and acceptability of and tolerance to supplement. RESULTS: Both groups showed an improvement in dry weight and BMI. In addition, the supplement group showed a significant increase in serum albumin level and functional scoring. Mild hyperphosphatemia occurred in the supplement group. An increase in baseline food intake was seen in the control group, but not in the supplemented group. No intolerance was reported to either supplement. CONCLUSION: Enteral nutrient supplementation was shown to bring about a significant improvement in serum albumin level even in a short-term study. Use of an HP supplement was beneficial, acceptable, and inexpensive. Copyright 2002 by the National Kidney Foundation, Inc.
机译:目的:采用高热量和高蛋白混合配方(低成本家庭制备的[HP]混合物或商业化合物或商业化合物或商业化合物或商业化合物或商业化合物,评估所述对照试验以评估所述短期肠内营养补充剂(MHD)患者的血液透析(MHD)患者的益处可用补充)并研究其对营养状况选定参数的影响。与商业营养补充剂(CNS)相比,还评估了HP混合配方,易用性和成本的可接受性和适口性。设计:随机对照试验。环境:印度南部的第三节推荐医院的血液透析(HD)单位。患者:非糖尿病成人MHD患者没有常规疾病,在招生前至少1个月的常规接触每周MHD,具有体重指数(BMI)<20和血清白蛋白水平<4.0g / dl。患者被随机分为对照组和实验组,后者又接受CNS或HP混合物。干预:控制Grooupreceed适当的监测,包括饮食召回和用于规定的饮食的咨询(蛋白质摄入1.2克/ kgibw / d的咨询,并且能量为35至45 kcal / kgibw / d),但没有特定的HD后补充剂。除了被监测的饮食处方外,补充组患者在补充组中收到了HD(提供了500kcal和15g蛋白)的相应补充剂后1个月。主要观察指标:(1)营养状况参数,BMI和血清白蛋白; (2)10点Karnofsky规模上的功能状态; (3)逆向代谢效应,研究开始和结束的高磷血症; (4)食欲的主观评分,并为补充的可接受性和可接受性和耐受性。结果:两组均显示干重和BMI的改善。此外,补充组显示血清白蛋白水平和功能评分显着增加。轻微的高磷血症发生在补充组中。对照组中观察到基线食物摄入量增加,但不在补充组中。据报道,没有任何不容忍。结论:肠内营养素仍显示出血清白蛋白水平的显着改善,即使在短期研究中也是如此。使用HP补充剂是有益的,可接受的,廉价的。版权所有2002由National Kidney Foundation,Inc。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号